Introduction/Background Anti-VEGF Dosing Regiments: Review of the Pertinent Studies Comparing the Anti-VEGF Dosing Strategies Conclusions References While ...
The SAILOR study, the largest trial in exudative AMD to date (n = 4307), was a Phase IIIb multicenter, 1-year study evaluating a variable-dosing regimen of 3-monthly intravitreal ranibizumab (0.3 ...
A 13-year-old male patient presented with a primary complaint of reduced vision in both eyes for the past 15 days at LV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback